Four years after shelter-in-place, covid-19 misinformation persists

FHS
April 1, 2024
11:27 am

From spring break parties to Mardi Gras, many people remember the last major “normal” thing they did before the novel coronavirus pandemic dawned, forcing governments worldwide to issue stay-at-home advisories and shutdowns.

First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) Anditixafortide (PentixaTher) – Biotech Investments

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Study First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y)

November 23, 2023

Opinion | It’s Time to Reform the Mysterious PBM System

Brown is an emergency medicine physician and business expert. I’m drinking coffee and eating cereal when yet another TV ad about pharmacy benefit managers (PBMs)

August 26, 2023

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization

Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.